191 related articles for article (PubMed ID: 36260525)
21. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma.
Zhu GG; Ramirez D; Chen W; Lu C; Wang L; Frosina D; Jungbluth A; Ntiamoah P; Nafa K; Boland PJ; Hameed MR
Hum Pathol; 2020 Oct; 104():73-83. PubMed ID: 32795465
[TBL] [Abstract][Full Text] [Related]
22. Predictive Value of Transforming Growth Factor-α and Ki-67 for the Prognosis of Skull Base Chordoma.
Zhang S; Bai J; Li M; Zhai Y; Wang S; Liu Q; Li C; Gui S; Zhang Y
World Neurosurg; 2019 Sep; 129():e199-e206. PubMed ID: 31125781
[TBL] [Abstract][Full Text] [Related]
23. First cytogenetic study of a recurrent familial chordoma of the clivus.
Dalprà L; Malgara R; Miozzo M; Riva P; Volonte M; Larizza L; Fuhrman Conti AM
Int J Cancer; 1999 Mar; 81(1):24-30. PubMed ID: 10077147
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma.
Morimoto Y; Tamura R; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Yoshida K; Toda M
J Neurooncol; 2019 Aug; 144(1):65-77. PubMed ID: 31240525
[TBL] [Abstract][Full Text] [Related]
25. Fascin expression in skull base chordoma: correlation with tumor recurrence and dura erosion.
Gao Z; Zhang Q; Kong F; Chen G; Li M; Guo H; Liang J; Bao Y; Ling F
Med Oncol; 2012 Dec; 29(4):2438-44. PubMed ID: 22351250
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling of chordoma.
Scheil-Bertram S; Kappler R; von Baer A; Hartwig E; Sarkar M; Serra M; Brüderlein S; Westhoff B; Melzner I; Bassaly B; Herms J; Hugo HH; Schulte M; Möller P
Int J Oncol; 2014 Apr; 44(4):1041-55. PubMed ID: 24452533
[TBL] [Abstract][Full Text] [Related]
27. High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.
Diaz RJ; Guduk M; Romagnuolo R; Smith CA; Northcott P; Shih D; Berisha F; Flanagan A; Munoz DG; Cusimano MD; Pamir MN; Rutka JT
Neoplasia; 2012 Sep; 14(9):788-98. PubMed ID: 23019410
[TBL] [Abstract][Full Text] [Related]
28. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma.
Rosenberg AE; Nielsen GP; Keel SB; Renard LG; Fitzek MM; Munzenrider JE; Liebsch NJ
Am J Surg Pathol; 1999 Nov; 23(11):1370-8. PubMed ID: 10555005
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor (EGFR) status in chordoma.
Ptaszyński K; Szumera-Ciećkiewicz A; Owczarek J; Mrozkowiak A; Pekul M; Barańska J; Rutkowski P
Pol J Pathol; 2009; 60(2):81-7. PubMed ID: 19886182
[TBL] [Abstract][Full Text] [Related]
30. Chordoma Occurs in Young Children With Tuberous Sclerosis.
Dahl NA; Luebbert T; Loi M; Neuberger I; Handler MH; Kleinschmidt-DeMasters BK; Mulcahy Levy JM
J Neuropathol Exp Neurol; 2017 Jun; 76(6):418-423. PubMed ID: 28498973
[TBL] [Abstract][Full Text] [Related]
31. Mandibular metastasis as a presenting feature of a clival chordoma.
Krishnamurthy A
J Cancer Res Ther; 2020; 16(3):668-671. PubMed ID: 32719288
[TBL] [Abstract][Full Text] [Related]
32. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
Li G; Cai L; Zhou L
Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
[TBL] [Abstract][Full Text] [Related]
33. Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?
Sawyer JR; Husain M; Al-Mefty O
Neurosurg Focus; 2001 Mar; 10(3):E6. PubMed ID: 16734409
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
35. MR Imaging Grading System for Skull Base Chordoma.
Tian K; Wang L; Ma J; Wang K; Li D; Du J; Jia G; Wu Z; Zhang J
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1206-1211. PubMed ID: 28428207
[TBL] [Abstract][Full Text] [Related]
36. [Dedifferentiated (sarcomatoid) chordoma in the base of the skull. Report of a case].
Losi L; Tomasich G
Pathologica; 1996 Dec; 88(6):514-8. PubMed ID: 9206780
[TBL] [Abstract][Full Text] [Related]
37. [Dedifferentiated chordoma of the skull base. A case report].
Sefiani S; Amarti A; Maher M; Benkiran L; Saidi A
Neurochirurgie; 2002 Nov; 48(5):436-9. PubMed ID: 12483123
[TBL] [Abstract][Full Text] [Related]
38. New developments in the pathology of skull base tumors.
Radner H; Katenkamp D; Reifenberger G; Deckert M; Pietsch T; Wiestler OD
Virchows Arch; 2001 Apr; 438(4):321-35. PubMed ID: 11355165
[TBL] [Abstract][Full Text] [Related]
39. Chordoma: Immunohistochemical Analysis of Brachury.
Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
[TBL] [Abstract][Full Text] [Related]
40. High expression of survivin independently correlates with tumor progression and mortality in patients with skull base chordomas.
Ma J; Tian K; Du J; Wu Z; Wang L; Zhang J
J Neurosurg; 2019 Jan; 132(1):140-149. PubMed ID: 30641849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
